Also, the hazardous ratio along with the TSG subtypes, gender, age, stage, smoking status, TMB, pT, pN, pM, dimension of sample/specimen (longest, shortest, and intermediate), location in lung parenchyma, and selected immune gene expressions was analyzed, and several parameters such as PLA2G2A, FCN3, and new tumor event after initial treatment in these clinical factors had some prognostic value with univariate analysis (PLA2G2A: HR = 1.6, P = 0.046, FCN3: HR = 1.8, P = 0.024, and new tumor event after initial treatment: HR = 1.8, p = 0.034, Table 1). The gene discussed is FCN3; the disease is neoplasm.